{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:54Z","timestamp":1793018454113,"version":"4.5.0"},"reference-count":48,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2021,3,15]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is limited information regarding the true frequency of nonmedical opioid use (NMOU) among patients receiving opioid therapy for cancer pain. Data to guide patient selection for urine drug testing (UDT) as well as the timing and frequency of ordering UDT are insufficient. This study examined the frequency of abnormal UDT among patients with cancer who underwent random UDT and their characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Demographic and clinical information for patients with cancer who underwent random UDT were retrospectively reviewed and compared with a historical cohort that underwent targeted UDT. Random UDT was ordered regardless of a patient's risk potential for NMOU. Targeted UDT was ordered on the basis of a physician's estimation of a patient's risk for NMOU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all, 552 of 573 eligible patients (96%) underwent random UDT. Among these patients, 130 (24%) had 1 or more abnormal results; 38 of the 88 patients (43%) who underwent targeted UDT had 1 or more abnormal results. When marijuana was excluded, 15% of the random group and 37% of the targeted group had abnormal UDT findings (<jats:italic>P<\/jats:italic> &lt; .001). It took a shorter time from the initial consultation to detect 1 or more abnormalities with the random test than the targeted test (median, 130 vs 274 days; <jats:italic>P<\/jats:italic> = .02). Abnormal random UDT was independently associated with younger age (<jats:italic>P<\/jats:italic> &lt; .0001), male sex (<jats:italic>P<\/jats:italic> = .03), Cut Down, Annoyed, Guilty, and Eye Opener\u2013Adapted to Include Drugs positivity (<jats:italic>P<\/jats:italic> = .001), and higher Edmonton Symptom Assessment System anxiety (<jats:italic>P<\/jats:italic> = .01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Approximately 1 in 4 patients receiving opioids for cancer pain at a supportive care clinic who underwent random UDT had 1 or more abnormalities. Random UDT detected abnormalities earlier than the targeted test. These findings suggest that random UDT is justified among patients with cancer pain.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.33326","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:06:52Z","timestamp":1606262812000},"page":"968-975","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Random urine drug testing among patients receiving opioid therapy for cancer pain"],"prefix":"10.1002","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-6108","authenticated-orcid":false,"given":"Joseph A.","family":"Arthur","sequence":"first","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-3527","authenticated-orcid":false,"given":"Zhanni","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-6607","authenticated-orcid":false,"given":"David","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden Mae","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Pharmacy Services The University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-8141","authenticated-orcid":false,"given":"Sriram","family":"Yennurajalingam","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2012-0563","authenticated-orcid":false,"given":"Shalini","family":"Dalal","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7283-0519","authenticated-orcid":false,"given":"Rony","family":"Dev","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-8675","authenticated-orcid":false,"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberson","family":"Tanco","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-8595","authenticated-orcid":false,"given":"Ali","family":"Haider","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane D.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-0412","authenticated-orcid":false,"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"195","article-title":"WHO cancer pain relief programme","volume":"7","author":"Stjernsward J","year":"1988","journal-title":"Cancer Surv"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(96)00109-1"},{"key":"e_1_2_8_4_1","first-page":"517","article-title":"Substance abuse issues in cancer patients. Part 1: prevalence and diagnosis","volume":"12","author":"Passik SD","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200207001-00009"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.20452\/pamw.741","article-title":"2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?","volume":"119","author":"Chou R","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.5206"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2011\/14\/123"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0525"},{"key":"e_1_2_8_11_1","first-page":"ES119","article-title":"Urine drug testing: current recommendations and best practices","volume":"15","author":"Owen GT","year":"2012","journal-title":"Pain Physician"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6756"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0120"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/082585979100700202"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050212"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00316-8"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-007-0247-6"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049909114531445"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26082"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0012"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.07.026"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2009.00743.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30240"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0248"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2012.07.001"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D632"},{"key":"e_1_2_8_28_1","first-page":"273","article-title":"An evaluation of the diagnostic accuracy of liquid chromatography\u2013tandem mass spectrometry versus immunoassay drug testing in pain patients","volume":"13","author":"Pesce A","year":"2010","journal-title":"Pain Physician"},{"key":"e_1_2_8_29_1","unstructured":"Mayo Clinic Laboratories.Pain Clinic Drug Screen Urine.https:\/\/www.mayocliniclabs.com\/test\u2010catalog\/Clinical+and+Interpretive\/36071. Accessed April 23 2020."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330300035030"},{"key":"e_1_2_8_31_1","first-page":"71","article-title":"Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review","volume":"7","author":"Carmichael AN","year":"2016","journal-title":"Subst Abuse Rehabil"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx178"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2167-6"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3575-1"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2017.s92"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01414.x"},{"key":"e_1_2_8_37_1","unstructured":"Washington State Agency Medical Directors' Group.Interagency Guideline on Prescribing Opioids for Pain.http:\/\/www.agencymeddirectors.wa.gov\/Files\/2015AMDGOpioidGuideline.pdf. Accessed April 23 2020."},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx285"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1373\/jalm.2017.023010"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00714-8"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2010\/13\/187"},{"key":"e_1_2_8_42_1","first-page":"167","article-title":"Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent Medicare policy changes in Kentucky","volume":"13","author":"Gilbert JW","year":"2010","journal-title":"Pain Physician"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199909000-00005"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.00072.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.02.014"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790340045007"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-032816-045128"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-016-0530-0"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0143-7"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.33326","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.33326","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.33326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:22:21Z","timestamp":1760260941000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.33326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,3,15]]}},"alternative-id":["10.1002\/cncr.33326"],"URL":"https:\/\/doi.org\/10.1002\/cncr.33326","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"2020-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}